| Primary |
| Depression |
42.9% |
| Colitis Ulcerative |
28.6% |
| Agitation |
14.3% |
| Anxiety |
14.3% |
|
| Drug Interaction |
14.3% |
| Dyskinesia |
14.3% |
| Heart Disease Congenital |
14.3% |
| Hepatitis |
14.3% |
| Nausea |
14.3% |
| Renal Impairment |
14.3% |
| Syncope |
14.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
32.8% |
| Anxiety |
14.1% |
| Schizophrenia, Paranoid Type |
7.8% |
| Bipolar Disorder |
6.3% |
| Depression |
4.7% |
| Alcohol Detoxification |
3.1% |
| Breast Cancer |
3.1% |
| Dyslipidaemia |
3.1% |
| Hypertension |
3.1% |
| Insomnia |
3.1% |
| Pain |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Psychotic Disorder |
3.1% |
| Anaemia |
1.6% |
| Confusional State |
1.6% |
| Disorientation |
1.6% |
| Hiv Infection |
1.6% |
| Influenza Like Illness |
1.6% |
| Urinary Tract Infection |
1.6% |
|
| Treatment Noncompliance |
17.6% |
| Hepatitis Cholestatic |
11.8% |
| Pyrexia |
11.8% |
| Renal Impairment |
11.8% |
| Alanine Aminotransferase Increased |
5.9% |
| Gastric Ulcer Haemorrhage |
5.9% |
| Haemorrhage |
5.9% |
| Hyponatraemia |
5.9% |
| Pancreatitis Acute |
5.9% |
| Syncope |
5.9% |
| Tibia Fracture |
5.9% |
| Urine Analysis |
5.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
12.7% |
| Hypertension |
12.7% |
| Osteoporosis |
10.2% |
| Pain |
8.6% |
| Prophylaxis |
7.0% |
| Insomnia |
6.6% |
| Anxiety |
6.4% |
| Product Used For Unknown Indication |
5.8% |
| Depression |
5.6% |
| Diabetes Mellitus |
3.8% |
| Nausea |
3.2% |
| Renal Cell Carcinoma Stage Unspecified |
2.4% |
| Epilepsy |
2.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.2% |
| Antifungal Prophylaxis |
1.8% |
| Breast Cancer |
1.8% |
| Infection Prophylaxis |
1.8% |
| Rheumatoid Arthritis |
1.8% |
| Metastatic Gastric Cancer |
1.6% |
| Osteoarthritis |
1.6% |
|
| Vomiting |
10.1% |
| Pyrexia |
8.7% |
| Angioedema |
5.8% |
| Arterial Thrombosis |
5.8% |
| Aspartate Aminotransferase Increased |
5.8% |
| Myocardial Infarction |
5.8% |
| Renal Failure |
5.8% |
| Hip Fracture |
4.3% |
| Hypoglycaemia |
4.3% |
| Hyponatraemia |
4.3% |
| Loss Of Consciousness |
4.3% |
| Mucosal Inflammation |
4.3% |
| Obsessive Thoughts |
4.3% |
| Pharyngolaryngeal Pain |
4.3% |
| Sepsis |
4.3% |
| Therapeutic Agent Toxicity |
4.3% |
| Transaminases Increased |
4.3% |
| Abdominal Pain |
2.9% |
| Breast Cancer |
2.9% |
| Capillary Leak Syndrome |
2.9% |
|
| Interacting |
| Depression |
30.0% |
| Ascites |
20.0% |
| Pain |
20.0% |
| Agitation |
10.0% |
| Anxiety |
10.0% |
| Insomnia |
10.0% |
|
| Drug Interaction |
33.3% |
| Hepatic Encephalopathy |
33.3% |
| Urine Analysis Abnormal |
33.3% |
|
